G069-0574 Screening compound: N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-1,3,3-trimethyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

G069-0574 Screening compound: N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-1,3,3-trimethyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide
G069-0574 Screening compound: N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-1,3,3-trimethyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G069-0574
N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-1,3,3-trimethyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G069-0574

Molecular Formula

C25H33N3O4S (C25 H33 N3 O4 S)

Compound Name

N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-1,3,3-trimethyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

N-({1-[(2-methoxyphenyl)methyl]piperidin-4-yl}methyl)-133-trimethyl-2-oxo-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(C)(c(cc(cc1)S(NCC2CCN(Cc(cccc3)c3OC)CC2)(=O)=O)c1N1C)C1=O

InChI

InChI=1S/C25H33N3O4S/c1-25(2)21-15-20(9-10-22(21)27(3)24(25)29)33(30,31)26-16-18-11-13-28(14-12-18)17-19-7-5-6-8-23(19)32-4/h5-10,15,18,26H,11-14,16-17H2,1-4H3

InChI Key

USKLEFMQDDFWJT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14978431

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.62

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.720

Distribution Coefficient, logD

1.937

Water Solubility, LogSw

-4.05

Polar Surface Area

68.866

Acid Dissociation Constant (pKa)

11.48

Base Dissociation Constant (pKb)

9.18

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

48.00

G069-0574 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Nervous system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with G069-0574 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G069-0574?
Check Price and Availability of G069-0574, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G069-0574 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G069-0574
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G069-0574
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G069-0574 available by request